An expert panel will discuss the latest research on CRISPR and how to use it in biotechnology and disease research.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...